HOME >> MEDICINE >> NEWS
Increase in effective contraceptive use can reduce abortion rate

Even modest increases in effective contraceptive use can reduce abortion rates, say two leading demographers. By developing a mathematical model that links the abortion rate to its direct determinants, Population Council scientist John Bongaarts and Princeton University professor Charles Westoff show how increased contraceptive use and effectiveness can reduce abortion rates. Their analysis is published in the September issue of the Population Council's journal, Studies in Family Planning.

Bongaarts and Westoff describe the relationship between a range of factors--number of reproductive years per woman, desired total fertility rate, abortion propensity, contraceptive prevalence, and the effectiveness of contraception--and the total abortion rate. The model allows them to estimate how reductions in abortion rates can be achieved by increases in contraceptive prevalence and effectiveness. According to their analysis, a woman who used no contraception would need about 12 abortions to restrict her fertility to two births.

For example, in a population with an abortion probability of 0.5 (meaning half of all unwanted pregnancies would end in abortion), a 10 percentage-point increase in contraceptive prevalence would avert approximately 0.45 abortions per woman, assuming contraception is 95 percent effective.

Worldwide about 133 million births occur annually; of these, experts estimate about 33 million (one-fourth) are unintended. In addition, an estimated 46 million induced abortions are performed, bringing the total number of unintended pregnancies to roughly 79 million per year. Almost as many unintended as intended pregnancies occur each year, and more than half of these unintended pregnancies end in abortion.

Several Factors Influence Rate of Abortion
The outcome of a pregnancy--whether it ends in a birth or induced abortion (miscarriages were excluded from the analysis)--depends on three factors: the desired number and spacing of births, the
'"/>

Contact: Sandra Waldman
swaldman@popcouncil.org
212-339-0525
Population Council
12-Sep-2000


Page: 1 2 3

Related medicine news :

1. Increased physical activity not linked to ALS risk
2. Increased suicide rate is possibly linked to chemicals released from nearby asphalt plants
3. Increased investment in radiotherapy will improve cure rates for European cancer patients
4. Increased use of CT in past decade results in decreased costs for hospitals
5. Increase in childhood leukaemia may be part due to increased light at night
6. Increased risk of cardiovascular disease shown in PCOS patients
7. Increase in prevalence of marijuana abuse and dependence
8. Increased HIV risk for women with violent male partners
9. Increased prevalence of diabetes - not all bad news
10. Increased heart mortality rates linked to lower state subsidies of uninsured in New Jersey
11. Increased parental mortality after death of a child

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Increase effective contraceptive use can reduce abortion rate

(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: